Estrella Immunopharma, Inc.
ESLA · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9 | -$7 | -$1 | -$2 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $0 | $0 |
| Change in WC | $1 | -$10 | $1 | $0 |
| Other Non-Cash | $1 | $0 | -$1 | -$0 |
| Operating Cash Flow | -$8 | -$16 | -$1 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$45 |
| Inv. Sales/Matur. | $0 | $0 | $36 | $0 |
| Other Inv. Act. | $0 | $5 | $0 | $0 |
| Investing Cash Flow | $0 | $5 | $36 | -$45 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $47 |
| Stock Repurch. | -$1 | -$0 | -$36 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $13 | $0 | $6 |
| Financing Cash Flow | -$0 | $13 | -$36 | $6 |
| Forex Effect | $0 | $0 | $0 | $45 |
| Net Chg. in Cash | -$8 | $2 | -$0 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9 | $2 | $0 | $0 |
| End Cash | $1 | $4 | $0 | $4 |
| Free Cash Flow | -$8 | -$16 | -$1 | -$1 |